Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ClearPoint Neuro Inc. - Common Stock (NQ:CLPT)

12.77 +0.58 (+4.76%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,096,377
Open 11.91
Bid (Size) 12.70 (500)
Ask (Size) 13.40 (400)
Prev. Close 12.19
Today's Range 11.33 - 13.59
52wk Range 8.270 - 30.10
Shares Outstanding 23,639,616
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
ClearPoint Neuro Q1 Earnings Call Highlights ↗
ClearPoint Neuro (NASDAQ:CLPT) reported record first-quarter 2026 revenue and reaffirmed its full-year outlook, as management highlighted growth in its legacy neurosurgical device business and early... 
Via MarketBeat
Topics Earnings
News headline image
ClearPoint (CLPT) Q1 2026 Earnings Transcript ↗
ClearPoint (CLPT) Q1 2026 Earnings Transcript 
Via The Motley Fool

Performance

YTD
-9.0%
-9.0%
1 Month
+27.6%
+27.6%
3 Month
-4.5%
-4.5%
6 Month
-23.6%
-23.6%
1 Year
-10.1%
-10.1%

More News

Read More
News headline image
ClearPoint Neuro Reports First Quarter 2026 Results
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint
Via ACCESS Newswire
ClearPoint Neuro Inc (NASDAQ:CLPT) Reports Q4 2025 Revenue Beat Amid Widened Loss, Shares Fall ↗
Via Chartmill
News headline image
ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint
Via ACCESS Newswire
News headline image
ClearPoint Neuro (CLPT) Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results
Via ACCESS Newswire
News headline image
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026
Via ACCESS Newswire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Get insights into the top gainers and losers of Monday's pre-market session. ↗
Via Chartmill
News headline image
ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
Via ACCESS Newswire
News headline image
ClearPoint Neuro Completes Acquisition of IRRAS
Via ACCESS Newswire
News headline image
ClearPoint Neuro Reports Third Quarter 2025 Results
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces Agreement to Acquire IRRAS
Via ACCESS Newswire
News headline image
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Via Benzinga
News headline image
Gapping stocks in Monday's session ↗
Via Chartmill
News headline image
Discover the top movers in Monday's pre-market session. ↗
Via Chartmill
News headline image
Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
ClearPoint Neuro Shares Are Trading Higher Wednesday: What's Going On? ↗
Via Benzinga
News headline image
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide
Via ACCESS Newswire

Frequently Asked Questions

Is ClearPoint Neuro Inc. - Common Stock publicly traded?
Yes, ClearPoint Neuro Inc. - Common Stock is publicly traded.
What exchange does ClearPoint Neuro Inc. - Common Stock trade on?
ClearPoint Neuro Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ClearPoint Neuro Inc. - Common Stock?
The ticker symbol for ClearPoint Neuro Inc. - Common Stock is CLPT on the Nasdaq Stock Market
What is the current price of ClearPoint Neuro Inc. - Common Stock?
The current price of ClearPoint Neuro Inc. - Common Stock is 12.77
When was ClearPoint Neuro Inc. - Common Stock last traded?
The last trade of ClearPoint Neuro Inc. - Common Stock was at 05/14/26 04:00 PM ET
What is the market capitalization of ClearPoint Neuro Inc. - Common Stock?
The market capitalization of ClearPoint Neuro Inc. - Common Stock is 301.88M
How many shares of ClearPoint Neuro Inc. - Common Stock are outstanding?
ClearPoint Neuro Inc. - Common Stock has 302M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.